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REVIEW
Background: Studies of mental disorders using single photon emission computed tomography
(SPECT) have been done for many years in China. Many results have been obtained. We
review these findings and introduce them to the outside world.
Methods: SPECT papers available on the Chinese Biomedical Bibliographic Database,
focusing on depression, schizophrenia, Alzheimer’s disease (AD), vascular dementia (VD),
anxiety disorder, and obsessive compulsive disorder (OCD) in China, were reviewed and the
results were compared with those obtained outside China.
Results: We found that regional cerebral blood flow (rCBF) was abnormal in mental disorders,
but the specificity of the abnormality is not yet consistent. Lower perfusion of rCBF could be
seen in frontal, temporal, and parietal lobes of patients with depression, AD, schizophrenia,
and VD. It seems that abnormality of the frontal lobe is more common in depression and
schizophrenia, but temporal lobe abnormalities are more common in AD and VD. The perfusion
of rCBF in the parietal lobe seems to be related to aging. Abnormalities in the occipital lobe
and basal ganglia seem to be more associated with vascular problems. Thalamic dysfunction
was mainly correlated with VD, and that of the cingulate largely with depression and
schizophrenia. Hippocampal abnormalities were associated with AD. There were few reports
on changes in anxiety disorders and other mental problems.
Conclusion: There is no specific biological marker of SPECT for individual mental disorders.
Further study is needed to provide more specific information on the pathophysiology of mental
disorders. It seems that brain abnormalities are similar in Chinese and non Chinese psychiatric
patients.
Keywords: depression, Alzheimer’s disease, vascular dementia, schizophrenia, anxiety
disorder, obsessive compulsive disorder, SPECT
Introduction
Functional brain imaging has assumed a leading role in neuropsychiatric research.
However, findings reported for mental disorders often vary. Whether this reflects
diversity in pathophysiology or heterogeneity of imaging techniques and data analysis
procedures is still unknown. Single photon emission computed tomography (SPECT)
is one of the techniques of functional imaging that can be used to detect regional
cerebral blood flow (rCBF) in the brain of subjects in different states. rCBF is closely
related to metabolism and physiology of the brain. The technique of SPECT was first
used in psychiatry in the early 1990s (Austin et al 1992), when it was found that
depressed patients showed reduced uptake in most cortical and subcortical regions
examined, most significantly in temporal, inferior frontal, and parietal areas. SPECT
was first used in the study of depression in China in 1995 (Deng et al 1995), then later in
schizophrenia, Alzheimer’s disease, and other mental disorders. Since then, many
studies have been made using SPECT in mental disorders in China. What are the results
of SPECT studies in China? What are the differences between these results in China
and those in other countries? Here we review SPECT studies in psychiatry in China.
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Method
We collected all SPECT papers focused on depression,
schizophrenia, Alzheimer’s disease, anxiety disorder, and
obsessive compulsive disorder published in the Chinese
language in China and available in the Chinese Biomedical
Bibliographic Database from 1990 to 2004. All publications
have been copyrighted and published openly in China. All
patients and researchers are Chinese. All overlapping articles
were excluded.
Results
We found a total of 31 articles fitting our defined criteria.
Three were excluded due to overlap. Six papers were studies
on depression (Deng et al 1995, 1997; Zhao et al 1998, 2000;
Jiang et al 2000; Ang et al 2003), 9 studied Alzheimer’s
disease (AD) (Jia and Gao 1996; Liu et al 1997; Ang, Jiang,
et al 1998; Ang, Zhang, et al 1998; Ang et al 1999, 2000;
Xu, Huang, et al 1999; Xu, Zheng, et al 1999; Peng et al
2001), and 13 others studied schizophrenia (Hu et al 1996;
Li, Deng, et al 1996; Li, Tang, et al 1996; Li, Zhao, et al
1996; Li et al 1997; Yu et al 1998; Li et al 2001; Zhou et al
2001; Li, Jiang, 2002; Li, Xiu, et al 2002; Liu et al 2002;
Wan et al 2002; Wang et al 2003). Only 1 study was found
on anxiety disorder (Wan et al 2002), 1 on obsessive
compulsive disorder (OCD) (Li, Jiang, et al 2002), and 1
on heroin addicts (Wang et al 2003).
Table 1 A review of SPECT papers on depression in China
Number Course Diagnostic criteria
Authors and age and method and tools rCBF results of patients
Deng et al 5 P < 2 yr first episode CCMD-2 Low  in  right temporal, frontal, parietal, and left
(1995) (23–60 yr, 40 ± 12) Self-control  HAMD occipital lobes; bilateral basal ganglia in 3 patients
99mTc-ECD (24 items) 22–43 with endogenous depression. Low in right temporal
1110 MBq lobe in reactive depression.
Deng et al 11 P (23–60 yr, 43 ± 12) 7 ± 3 m CCMD-2 Low  in  left inferior frontal, left anterior temporal,
(1997) 13 C (20–59 yr, 42 ± 14) Drug free or stop for HAMD (24 items)  and cingulate. Low in right superior, inferior frontal
1 wk to 12 m 38.9 ± 10.8 and bilateral parietal, and occipital lobes. Asymmetry
99mTc-ECD in  right superior frontal.
925–1225 MBq 
ROI
Zhao et al 27 P (17–51 yr, 33 ± 11) 3 m–2 yr first episode ICD-10 Low in left frontal, temporal lobes in baseline and
(1998) 15 C (20–53 yr, 36 ± 12) drug free  WCST activated. Low in left parietal lobe only in activated.
 
99mTc-ECD  HAMD (24 items) 
1110 MBq  31–38
ROI
Zhao et al 39 P (17–55 yr) 3 m–2 yr first episode ICD-10 Low in bilateral frontal and temporal lobes both at
(2000) 17 C (21–50 yr) drug free  CCMD-2-R  baseline and activated, but low in parietal lobe only
18ED (62–76 yr)  99mTc-ECD  WCST at  activated in non-old patients. Low in bilateral
21C (60–72 yr ) ROI HAMD (24items)  frontal, temporal lobes, and right basal ganglia both at
24–49 baseline and activated in old patients with
depression, but right parietal only at activated.
Jiang et al 22 ED (67 ± 4yr) No course, first ICD-10  RAR: Low in bilateral basal ganglia, frontal, and
(2000) 26 C (68 ± 4yr) episode HAMD (24 items) occipital lobes; right parietal lobe and thalamus.
99mTc-ECD  MMSE Cognitive disorder related to bilateral occipital, left
925–1110 MBq temporal lobe.
ROI 
RAR
Ang et al 22 ED (67 ± 4 yr) No course, first DSM-IV Low  in  right parietal, bilateral frontal and occipital
(2003) 26 C (68 ± 4 yr) episode of ED HAMD (24-items)  lobes. Perfusion asymmetry in temporal, frontal and
26 AD (68 ± 7 yr) Drug free  MMSE  occipital lobes lower in left than right but thalamus
ROI  lower in right than left. Increase in bilateral temporal
RAR lobe, basal ganglia, thalamus, and cingulate in patients
with depression compared with AD patients.
Abbreviations: AD, Alzheimer’s disease; C, controls; CCMD-2, Chinese Classification of Mental Disorders-2; DSM-IV, Diagnostic and statistical manual of mental
disorders, 4th edition; ED, elderly depression; HAMD, Hamilton depression scale; ICD-10, The ICD-10 classification of mental and behavioural disorders, clinical
description and diagnostic guideline; MMSE, mini-mental state examination; m, month; P, patients; RAR, radioactive ratios; ROI, regions of interest; wk, week; WCST,
Wisconsin card sorting test; yr, years.Neuropsychiatric Disease and Treatment 2006:2(1) 45
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Depression
As shown in Table 1, there was only 1 retrospective study,
which included just 5 patients (Deng et al 1995). Patients
with reactive depression showed low rCBF only in the right
temporal lobe whereas subjects with endogenous depression
displayed low rCBF both in the right temporal lobe and the
right frontal-parietal lobe. Five other papers concerned
prospective controlled studies with larger samples, from 11
to 39 subjects, using ICD-10, DSM-IV, CCMD-2, and
CCMD-2-R criteria.
All 6 studies found lower rCBF in the frontal lobe of
patients with depression than in controls: 1 was in the right
frontal (Deng et al 1995), 2 in the left frontal (Deng et al
1997; Zhao et al 1998), and 3 were bilateral (Jiang et al
2000; Zhao et al 2000; Ang et al 2003). Four authors found
lower rCBF in the temporal lobe also (Deng et al 1995, 1997;
Zhao et al 1998, 2000). Five studies found lower rCBF in
the parietal lobe, mainly in the right (Deng et al 1995, 1997;
Jiang et al 2000; Zhao et al 2000; Ang et al 2003). Four
studies showed lower rCBF in the occipital lobe, 1 in the left
(Deng et al 1995), the other in the right (Deng et al 1997),
and 2 in both sides in older-age depression (Jiang et al 2000;
Ang et al 2003). Three studies also reported lower rCBF in
basal ganglia, 2 on both sides (Deng et al 1995; Jiang et al
2000), but 1 only in the right side of old patients (Zhao et al
2000). Three studies dealt with old patients with depression;
the results showed lower rCBF in the right parietal lobe (Zhao
et al 2000; Ang et al 2003), and only 1 study showed lower
rCBF in the left parietal in the activated state (Zhao et al
1998). Patients in the studies of Jiang et al (2000) and Ang
et al (2002) were the same. Only Deng (1997) reported lower
rCBF in cingulate, and only Jiang et al (2000) in the thalamus.
Perfusion asymmetry in temporal, frontal, and occipital lobes
was observed in 2 studies, with lower perfusion in the left
than in the right. Also perfusion in the thalamus was lower
in the right than in the left (Deng et al 1997; Ang et al 2003).
Three studies used patients with first-episode depression
(Zhao et al 1998; Jiang et al 2000; Ang et al 2003).
Table 2 A review of SPECT studies on Alzheimer’s disease in China
Number Course Diagnostic criteria
Authors and age and method and tools rCBF results of patients 
Jia et al AD 9 (53–81 yr, 64 ± ??) No course ICD-10  Low in frontal-parietal lobe 3 cases, in temporal-
(1996) VD 10 (52–70 yr, 59 ± ??) 99mTc-ECD NINCDS-ADRDA parietal lobe, parietal lobe, and frontal-temporal lobe
VD Hachinski scale > 7  each 1 case in AD. Results of patients with VD same
AD Hachinski scale < 4  with CT results; no detailed description.
CT scan
WAIS
Liu et al VD 33 (50–70 yr, 61 ± 6) 0.5–3 yr DSM-III-R Low  in  left frontal and temporal lobe related to VIQ
(1997) AD 21 (52–76 yr, 60 ± 7)  VD 1.6 ± 0.6 VD Hachinski scale > 7  in VD, but low in left temporal and right frontal lobe
C 24 (51–68 yr, 59 ± 6) AD 3.1 ± 0.6 AD  Hachinski scale < 4  with VIQ in AD. Low in left frontal, and right parietal,
99mTc-ECD WAIS  thalamus related to FIQ in VD, but low in right
740–825 MBq WMS parietal and occipital with PIQ in AD.
self-statistic method HRNB
for radio-number
Ang, Zhang, AD 36 (71 ± 6 yr) No  course DSM-IV Compared with control subjects, low in all lobes
et al (1998) VD 35 (72 ± 4 yr)  99mTc-ECD CT  scan  except bilateral occipital in AD. Compared with
C 37 (70 ± 4 yr) 925–1110 MBq  VD Hachinski scale > 7 control subjects, low in all parts except right
ROI occipital and bilateral frontal in VD. Comparing VD,
low in bilateral frontal and right parietal lobe in AD.
Ang, Jiang, AD 17 (51–80 yr, 70 ± 8)  No course DSM-IV Abnormal rate (%) of AD was 38.2 in frontal, 47.1 in
et al (1998) VD 12 (67–82 yr, 73 ± 5)
99mTc-ECD VD  Hachinski scale > 7  temporal, 52.9 in parietal, and 5.9 in occipital lobes.
925–1110 MBq  AD Hachinski scale < 4  Lower in left superior and inferior temporal lobe
ROI MMSE  than in right within AD group. Abnormal rate (%) of
RAR CT or MRI scan VD was 50.0 in frontal, 58.3 in temporal, 33.3 in
parietal, and 16.7 in occipital lobes, 12.5 in basal
ganglia and 8.3 in thalamus. Lower in left superior
and inferior temporal, left parietal, and left occipital
lobes than in right lobes within VD group. Lower in
right inferior temporal and right occipital in AD than
in VD, but higher in left parietal in AD than in VD.
continued overleafNeuropsychiatric Disease and Treatment 2006:2(1) 46
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Table 2 continued
Number Course Diagnostic criteria
Authors and age and method and tools rCBF results of patients 
Xu, Huang, VD 30 (62–89 yr, 75 ± 6) VD  2.5 yr DSM-III-R Lower  in  all lobes except frontal lobe, right occipital
et al (1999) PD 31 (61–90 yr, 74 ± 6) PD  3yr NINDS-AIREN  and left thalamus in VD than in control. Lower in
C 30 (60–78 yr, 71 ± 4)
99mTc-ECD VD  Hachinski scale > 7 parietal, temporal, basal ganglia and thalamus in PD
925–1110 MBq  MMSE than in control. Lower in left temporal lobe than that
RAR CT scan of right in PD. No difference between VD and PD.
NPT
Ang et al AD 36 (71 ± 6 yr) No course  DSM-IV Results of RAR: Lower in all lobes except bilateral
(1999) VD 35 (72 ± 4 yr)
99mTc-ECD CT  scan occipital lobe in AD than in control. Lower in all
C 37 (70 ± 4 yr) 925–1110 MBq VD Hachinski scale > 7  lobes except right occipital and bilateral frontal lobes
ROI  MMSE in VD than in control. Lower in right parietal and
RAR NPT bilateral frontal in AD than in VD.
Xu, Zheng, AD 15 (59–79yr, 69±6) No course DSM-III-R Lower in AD and VD than in control. Lower in frontal,
et al (1999) VD 24 (43–83yr, 70±9) 99mTc-ECD NINCDS-ADRDA temporal, and parietal lobe in AD group than in
C 15 (50–85yr, 66±9) Patlak plot analysis MMSE control. Lower in all lobes and basal ganglia in VD
Hachinski scale group than that of control. Low in temporal and
parietal related to MMSE in AD. No report compared
AD and VD.
Peng et al AD 36 (60–84 yr, 71 ± 8) 7–29 m (16 ± 8)  DSM-III-R Lower in AD and VD than in control. Lower in
(2001) VD 32 (60–81 yr, 70 ± 8) 3–30 m (17 ± 8) NINCDS-ADRDA  temporal, frontal, parietal and hippocampus in AD
C 30 (60–83 yr, 70 ± 8)
99mTc-ECD MMSE  than in control. Lower in temporal, parietal, frontal,
925–1110 MBq Hachinski scale thalamus and basal ganglia in VD than in control. The
RAR MRI severity of AD was related to lower rCBF in
hippocampus.
Ang et al AD 66 (60–65, 9  No course DSM-IV Lower  in  bilateral temporal, frontal, and parietal
(2002) 66–70, 14  RAR MMSE  lobes in AD than in control. No difference between
> 70, 43) MRI 60–65, 66–70, > 70 years-old groups.
C 73 (60–65, 25 
66–70, 23
> 70, 25)
Abbreviations: AD, Alzheimer’s disease; C, control, CT, computer tomography; DSM-IV, DSM-III, Diagnostic and statistical manual of mental disorders, 4th edition, 3rd
edition; FIQ, final IQ; Hachinski, Hachinski ischemic score; HRNB, Halstead-Reitan neuropsychological battery; ICD-10, The ICD-10 classification of mental and
behavioural disorders, clinical description and diagnostic guideline; m, month; MMSE, mini-mental state examination; MRI, magnetic resonance imaging; NINCDS-
ADRDA, National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer’s Disease and Related Disorders Association; NINDS-AIREN,
National Institute of Neurological Disorders and Stroke-Association
 Internationale pour la Recherche et l’Enseignement en Neurosciences
 ; PD, Parkinson’s disease,
PIQ, practice IQ; RAR, radioactive ratios; ROI, regions of interest; VD, vascular dementia; VIQ, verbal IQ, WAIS, Wechsler’s adult intelligence scale; WMS, Wechsler’s
memory scale; NPT, neuropsychological test; yr, year;
Alzheimer’s disease
We found that all of the 8 papers dealing with AD reported
lower rCBF in frontal, temporal, and parietal lobes (Table 2)
(Jia and Gao 1996; Liu et al 1997; Ang, Jiang, et al 1998;
Ang, Zhang, et al 1998; Ang et al 1999; Xu, Zheng, et al
1999; Peng et al 2001; Ang et al 2002). In contrast, 3 of 9
studies did not find that rCBF was significantly lower in the
frontal lobe of patients with vascular dementia (VD) (Ang,
Zhang, et al 1998; Ang et al 1999; Xu, Huang et al 1999).
Three articles showed that rCBF was also lower in the
basal ganglia of patients with VD (Ang, Jiang, et al 1998;
Xu, Zheng et al 1999; Peng et al 2001), but Xu, Huang et al
(1999) found the same result only in patients with
Parkinson’s disease (PD), not in the VD group. Three authors
found rCBF to be lower in the thalamus of VD patients (Ang,
Jiang, et al 1998; Xu, Huang, et al 1999; Peng et al 2001),
and 1 reported lower perfusion of rCBF in the hippocampus
of AD patients (Peng et al 2001). There were 5 reports of
lower rCBF in the occipital lobe (Liu et al 1997; Ang, Jiang,
et al 1998; Ang, Zhang, et al 1998; Ang et al 1999; Xu,
Huang, et al 1999), 4 in patients with VD and 1 in AD.
rCBF in frontal, temporal, and parietal lobes in patients with
AD was significantly lower than in patients with VD, some
bilaterally and others in the right lobes only (Ang, Zhang,
et al 1998; Ang et al 1999; Xu, Zheng, et al 1999).
Schizophrenia
Because 3 of the 13 papers about schizophrenia overlapped
with other articles, we have included only 10 papers in
Table 3. Most were controlled studies, with only 2 reportsNeuropsychiatric Disease and Treatment 2006:2(1) 47
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Table 3 A review of SPECT studies on schizophrenia in China
Number Duration Diagnostic criteria
Authors and age  and method  and tools rCBF results of patients
Li, Tang, et al 32 S G 1, 0.3–2.9 yr  ICD-10 The abnormality of SPECT in group schizophrenia
(1996) G1, 14 18–54 yr  First time untreated CCMD-2  was 93.8% lower in bilateral frontal, left temporal
G2, 18 25–58 yr G 2, 5–18 yr CT lobes, and right basal ganglia in schizophrenia. Lower




Li, Deng, et al 9 S 31 ± 12 yr 20 d–17 yr No  CCMD-2 Low in right temporal in all patients. Low in bilateral
(1996)
99mTc-ECD temporal and frontal in 6 patients, and right parietal
925–1225 MBq and left occipital in 4 patients.
Hu et al 22 S 18–42 yr 6 m–21 yr  CCMD-2 4 patients with abnormal rCBF at baseline. Left
(1996) 10 C 18–33 yr ROI  frontal activation deficit.
99mTc-ECD
740 MBq
Li, Zhao, et al 25 S1 (negative 0.8–20 yr (9 ± 6 yr)  CCMD-2 Lower in frontal, temporal and basal ganglia in both
(1996) group) 16–54 yr 0.3–20 yr (5 ± 5 yr) groups than in control, but no significant differences
25 S2 (non-negative Nickel’s analysis  within patients. No abnormalities in control group.
group) 18–58 yr 
99mTc-ECD
21 C 1110 MBq
Liu et al 12 S 18–45 yr No course recorded  DSM-IV Lower  in  left frontal than that of right lobe, no
(1997) Drugs free within a CCMD-2-R increase in left frontal lobe after WCST. Negative
month WCST symptoms might be related to left frontal lobe.
Pan’s analysis Andreasen’s negative
99mTc-ECD schizophrenia
12 mic–18 mic diagnostic criteria
Yu et al 22 S 0.5–9.9 yr CCMD-2 Low  in  left frontal in both negative groups. Lower in
(1998) high negative group,
99mTc-ECD  SANS  right superior frontal in group of high score of
9, 31 ± 9 yr 740  MBq BPRS  SANS.
low negative group, ROI analysis WCST
13, 29 ± 7 yr 
10 C 26 ± 5 yr
continued overleaf
on schizophrenia patients without controls (Li, Deng, et al
1996; Liu et al 1997). We found low rCBF in the frontal
lobe of patients with schizophrenia in all 10 papers. Some
were in the left frontal, others in the right, and some bilateral.
Six studies reported lower rCBF also in the temporal lobe
in schizophrenia (Li, Deng, et al 1996; Li, Tang, et al 1996;
Li, Zhao, et al 1996; Li et al 2001, 2002; Liu et al 2002).
Three authors found lower rCBF in the parietal lobe (Li,
Deng, et al 1996; Zhou et al 2001; Liu et al 2002). Two
reports found lower rCBF also in basal ganglia (Li, Zhao,
et al 1996; Liu et al 2002), but there were only single reports
of lower rCBF in the occipital lobe, thalamus, or cingulate
respectively (Li, Deng, et al 1996; Zhou et al 2001; Liu et al
2002). Two reports measured changes of rCBF before and
after antipsychotic treatment; 1 reported that rCBF increased
by about 50% along with the positive symptoms but did not
identify individual antipsychotics, while the other study
detected no significant change after risperidone therapy for
8 weeks (Zhou et al 2001; Liu et al 2002).
We found only 1 paper on OCD, 1 in anxiety disorder,
and 1 in heroin addicts (Table 4). rCBF was low in many
brain regions such as frontal, temporal, parietal, occipital,
thalamus, basal ganglia, vermis, pons, amygdala, precuneus,
putamen, cingulated, and orbital gyrus. More studies are
needed in these psychiatric disorders in patients in China.
Discussion
To date, only 6 SPECT studies have been made on
depression in China. rCBF was significantly lower in many
brain regions, eg, frontal, temporal, parietal, occipital, basal
ganglia, cingulate, and thalamus. While all of the studies
found rCBF to be low mainly in the frontal, and to be related
to depression in the basal state, some researchers found
rCBF to be lower in the right but others in the left or even toNeuropsychiatric Disease and Treatment 2006:2(1) 48
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be bilateral frontal. Most reported that rCBF was also low
in temporal, parietal, and occipital lobes during depression.
The results of low rCBF in frontal and temporal lobes in
China are similar to those in North American and Japanese
patients (Mayberg et al 1994; Ito et al 1996; Meltzer et al
1998; Nobler et al 1999). So it seems that the frontal cortex
plays an important role in the expression of depression (Ariel
et al 2004). Three reports about old patients with depression
in Table 1 showed low rCBF low perfusion in basal ganglia
(Jiang et al 2000; Zhao et al 2000; Ang 2003), which agrees
with findings in North American patients (Buchsbaum et al
1997; Brody et al 2001). Only 1 paper (Deng et al 1997)
found that low rCBF in cingulate was correlated with
depression in Chinese patients, which supports the original
results in North America of Austin et al (1992).
The first SPECT study in Alzheimer’s disease (AD) was
reported early in 1990 (Battistein et al 1990). Many
nonChinese reports confirmed that perfusion of rCBF was
significantly lower in temporal and parietal lobes of patients
with AD (Formarelli et al 1996). Chinese studies in Table 2
showed that the rCBF was significantly lower in frontal,
temporal and parietal lobe of patients with AD than that of
control subjects. Some researchers found rCBF asymmetry
in right and left; Ang, Jiang, et al (1998) reported that rCBF
was lower in left than in right temporal lobe in AD, and
lower in left than in right temporal, parietal, and occipital
lobes in the VD group. Celsis et al (1997) considered that
asymmetry of hypoperfusion in the temporal–parietal lobe
was a predictor of cognitive defect to differentiate AD from
aging-related cognitive changes in North American patients.
Ang, Zhang, et al (1998) found that rCBF in AD was lower
in bilateral frontal and right parietal lobes than in VD, but
also reported lower perfusion of rCBF in the right temporal
and right occipital in AD than that in VD; left parietal rCBF
in AD was also higher than that of the VD group (Ang,
Jiang, et al 1998).
Table 3 continued
Number Duration Diagnostic criteria
Authors and age  and method  and tools rCBF results of patients
Li et al 24 S 18–50 yr 10.8 ± 14.3 m ICD-10 Before  treatment with risperidone, rCBF was higher
(2001) 26 C 18–50 yr untreated SANS in  bilateral inferior posterior temporal lobe at
99mTc-ECD  SAPS baseline, but lower in left mid-lateral frontal after
925–1110 MBq PANSS cognitive activation. After treatment rCBF significantly
ROI analysis WCST lower in right lateral temporal, bilateral superior
posterior temporal lobe. After cognitive activation
rCBF increase in bilateral inferior medial frontal, left
inferior lateral frontal, left superior fronto-temporal,
and left superior lateral frontal.
Zhou et al 22 S Age 18–55 yr 1–3 yr  CCMD-2-R Abnormality in 82% (18/22). Lower in right frontal,
(2001) 10 C Age 21–47 yr
99mTc-ECD parietal, temporal, and cingulate in schizophrenia
925–1110 MBq group than in control. 8 patents tested before and
SPM  after treatment, 100% abnormal before treatment,
ROI and 50% still abnormal after treatment. Significant
changes in right frontal and temporal lobes.
Li et al 32 S 18–50 yr 12.3 ± 20.0 m ICD-10 The baseline ratio of rCBF was higher in bilateral
(2002) 26 C 18–50 yr untreated Paranoid type  inferior posterior temporal lobe but lower in right
99mTc-ECD  WCST frontal-temporal and left mid-medial frontal. 
925–1110 MBq
ROI
Liu, Xiu, 21 S Age 52–76 yr 6–54 m  DSM-III-R Lower in left frontal, parietal, bilateral inferior
et al (2002) (61 ± 7 yr) First episode late CT temporal lobes, basal ganglia, right thalamus. Lower in
20 C Age 54–75 yr onset MRI left frontal than in right. RARS was not significantly
(65 ± 5 yr) 99mTc-ECD  MMSE changed in all regions after treatment with
925–1110 MBq  WCST risperidone for 8 weeks in 11 patients.
ROI
RAR
Abbreviations: BPRS, brief psychiatric rating scale; CCMD-2-R, Chinese Classification of Mental Disorders-2-revision; CT, computerised tomography; C, controls; d,
days; DSM-IV, Diagnostic and statistical manual of mental disorders fourth edition; G, group; ICD-10, the ICD-10 classification of mental and behavioural disorders,
clinical description and diagnostic guideline; m, months; MMSE, MMSE, mini-mental state examination; MRI, magnetic resonance imaging; PANSS, positive and negative
syndrome scale; RAR, radioactive ratios; ROI, regions of interest; SANS, scale for assessment of negative symptoms; SAPS, scale for assessment of positive symptoms;
S, schizophrenia; SPM, statistical parametric mapping; WCST, Wisconsin card sorting test; yr, years.Neuropsychiatric Disease and Treatment 2006:2(1) 49
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Peng et al (2001) found the severity of AD to be
associated with low perfusion of rCBF in the hippocampus.
Four of 8 papers including VD patients did not show low
rCBF in the frontal lobe (Jia et al 1996; Ang, Zhang, 1998;
Ang et al 1999; Xu, Huang, et al 1999). Some investigators
also found lower rCBF in the thalamus and basal ganglia in
patients with VD (Liu et al 1997; Ang, Jiang, et al 1998;
Xu, Huang, et al 1999; Peng et al 2001), but the results for
the occipital lobe were contradictory.
Schizophrenia is a common disorder. According to the
10 papers listed in Table 3, all researchers found that rCBF
perfusion was significantly lower in the frontal lobe of
patients with schizophrenia, many of them showing
problems also in the left side. Most of the studies (Jia and
Gao 1996; Ang, Zhang, et al 1998) in Table 3 also showed
lower rCBF occurring in the temporal lobe, with some
reporting lower rCBF bilaterally and others finding it in the
right or left temporal lobe; the results at present are
inconsistent. These results are similar to those in nonChinese
patients (Andreasen et al 1992; Wolkin et al 1992; Woods
et al 1992). Li, Guifang, et al (1996) found that there was
no significant difference between negative and positive
symptoms in terms of lower perfusion of rCBF, both types
being associated with lower rCBF in the brain, but Yu et al
(1998) and Li et al (2001) reported that the negative
symptoms of schizophrenia might be related to the perfusion
of rCBF in the left frontal lobe. Andreasen et al (1992) and
Rubin et al (1994) found similar results in nonChinese
patients.
After treatment with risperidone, Li et al (2001) found
that perfusion in the thalamus and superior posterior
temporale was decreased significantly, with parallel
improvement in positive symptoms, similar to that in
nonChinese reports (Berman et al 1996; Sabri et al 1997;
Malaspina et al 1999; Puri et al 2001).
For late-onset schizophrenia, Liu et al 2002 found lower
rCBF in the left frontal, left parietal, bilateral temporal,
bilateral basal ganglia, and right thalamus (Liu et al 2002),
similar to the nonChinese results of Lesser et al (1993),
Dupont et al (1994), and Sachdev et al (1997).
There were few studies of other mental disorders in
China, with only 1 paper on OCD, one on anxiety disorders,
and one on heroin addicts (Table 4). Li et al (2002) found
that the results of rCBF were different with different ways
of analysis, rCBF being lower in the right anterior temporal,
temporo-parietal, and left temporo-occipital lobes of patients
with OCD using the regions of interest (ROI) method, but
low in bilateral putamen, superior temporal gyrus,
precuneus, right orbital gyrus, superior and middle frontal
gyrus, left temporo-occipital lobes, superior parietal gyrus,
vermis with SPM analysis. Wan et al (2002) found that
rCBFs of brain were generally decreased under stressor
stimulation, similar to the findings in nonChinese patients
of Lucky et al (1997). Wan et al (2002) did not find low
Table 4 A review of SPECT studies on other mental disorders in China
Number Duration Diagnostic criteria
Authors and age and method and tools rCBF results of patients
Li, Jiang, et al 14 OCD (30 ± 12 yr) No record ICD-10 Low in bilateral putamen, superior temporal lobe,
(2002) 23 C no record 99mTc-ECD Yale Brown gyrus, precuneus, right orbital gyrus, superior and
740 MBq  obsessive-compulsive middle frontal gyrus, left temporal-occipital lobe,
SPM and ROI scale superior parietal gyrus, and vermis with SPM
analysis. Low in right anterior temporal lobe,
temporal-parietal lobe, and left temporal-occipital
lobe with ROI analysis.
Wan et al  20 ANX 25–63 yr No  record CCMD-2-R  Lower in frontal, temporal lobes, thalamus and basal
(2002) 20 C 22–60 yr
99mTc-ECD HAMA  ganglia at baseline state. Lower in pons, frontal,
925–1110 MBq  HAMD temporal, parietal, occipital lobes, thalamus, and basal
ROI ganglia during stress condition. Significant increase
in all regions of patients after modified stressor
stimulation.
Wang et al 25 ADI 20–45 yr No record  DSM-IV Increase in frontal, temporal lobes, and amygdala
(2003)
99mTc-ECD during exposure to heroin-related cues.
925–1110 MBq 
ROI and RAR
Abbreviations: ADI, heroin addict; ANX, anxiety disorder; CCMD-2-R, Chinese Classification of Mental Disorders-2-revision; DSM-IV, Diagnostic and statistical
manual of mental disorders fourth edition; HAMA, Hamilton anxiety scale; HAMD, Hamilton depression scale; ICD-10, The ICD-10 classification of mental and
behavioural disorders, clinical description and diagnostic guideline; OCD, obsessive compulsive disorder; RAR, radioactive ratios; ROI, regions of interest; yr, years.Neuropsychiatric Disease and Treatment 2006:2(1) 50
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perfusion in the cerebellum, but Bonne et al (2003) found
the abnormality in nonChinese PTSD patients. Wang et al
(2003) indicted that frontal, temporal, and amygdala rCBF
changes were associated with relapsing processes during
exposure to heroin-related cues.
According to all the above studies, we found that
perfusion of rCBF was abnormal in mental disorders, but
the specificity of the abnormality is not consistent. From
Table 5, we know that lower rCBF could be seen mostly in
frontal, temporal, and parietal lobes of patients with
depression, AD, schizophrenia, and VD. It seems that the
abnormality of the frontal lobe is more common in
depression and schizophrenia, but temporal lobe abnormality
is more common in AD and VD. The perfusion of rCBF in
the parietal lobe seems related to aging, because older
patients seem to have lower perfusion of rCBF. The
abnormality in the occipital lobe and basal ganglia seems
to have an association with vascular problems according to
the results presented in Table 5, supporting the hypothesis
of vascular depression for old patients. The problem in the
thalamus was correlated mainly with VD, and in the
cingulate largely with depression and schizophrenia. One
paper found AD associated with the hippocampus. There
were few reports of anxiety disorders and other mental
problems. It seems likely that brain abnormalities in Chinese
psychiatric patients are similar to those in nonChinese
populations, at least as measured by rCBF changes in SPECT
studies. We need multicenter, large-sample, same-diagnosis-
criteria, prospective, controlled, collaborative studies across
populations to provide more specific information on the
pathophysiology in mental disorders.
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